Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced Anal Canal Squamous Carcinoma Patients

NCT05060471 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT05060471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05060471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced Anal Canal Squamous Carcinoma Patients
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Completed
Start date
October 27, 2021
Completion date
November 27, 2024
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal canal cancer, anal canal cancer stage i, anal canal cancer stage ii, anal canal cancer stage iii, anal cancer, anal squamous cell carcinoma